May 1, 2018 - The 23-valent pneumococcal polysaccharide vaccine (PPSV23; Pneumovax 23) decreases the relative risk of community-acquired pneumonia in adults by 13%. The risk is reduced by 28% in the population that includes adults older than 65 years, those with lung disease, and those living in a ...
American Family Physician : FPIN's Help Desk Answers
Jul 15, 2018 - The American College of Physicians and Centers for Disease Control and Prevention highlights the consensus among these recommendations, with recent evidence, to develop a best practice advice statement for vaccination, screening, care, and treatment of patients at risk of or who ...
American Family Physician : Practice Guidelines
Oct 15, 2018 - Recombinant zoster vaccine is a relatively new shingles vaccine that has been shown to have greater effectiveness and protection than the existing live vaccine. Local and systemic adverse effects may occur after administration, but have been shown to resolve within one to three days.
American Family Physician : STEPS
Feb 1, 2020 - In June 2019, the Advisory Committee on Immunization Practices approved a change from its age-based 13-valent pneumococcal conjugate vaccine recommendations to a shared clinical decision-making process.
American Family Physician : Editorials
Aug 1, 2019 - Influenza vaccination reduces rates of laboratory-confirmed influenza and symptomatic influenza-like illness in healthy children, healthy adults, and older adults. There is no consistent evidence that influenza vaccination reduces school absenteeism in children, parental absenteeism ...
American Family Physician : Cochrane for Clinicians
navigate_before 1 navigate_next